A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo

Cited by papers we hold 6

• The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer · 2022
  No notice
• System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy · 2022
  No notice
• The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy · 2021
  No notice
• Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers · 2021
  No notice
• Metabolic reprogramming in triple-negative breast cancer · 2020
  No notice
• Targeting ferroptosis in breast cancer · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.